TDC
ANGO icon

Thompson Davis & Co’s AngioDynamics ANGO Stock Holding History

Thompson Davis & Co’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$5K Hold
250
– – 0.01% 560
2018
Q2 		$6K Buy
+250
New +$5.11K 0.01% 491
2014
Q2 		– Sell
-500
Closed -$8K – 759
2014
Q1 		$8K Hold
500
– – 0.01% 531
2013
Q4 		$9K Buy
+500
New +$7.69K 0.01% 460

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Thompson Davis & Co's ANGO Position: Q3 2018 in Review

Thompson Davis & Co held its AngioDynamics (ANGO) position steady in Q3 2018 at 250 shares worth $5K. The position accounts for 0.01% of the portfolio, ranked #560.

Thompson Davis & Co first reported a position in ANGO in Q4 2013 and has held it in 4 quarters since. The position peaked at $9K in Q4 2013. 177 funds tracked by Wall St. Rank hold ANGO as of Q3 2018.

  • Thompson Davis & Co held 250 shares of AngioDynamics worth $5K as of Q3 2018.
  • Thompson Davis & Co left its AngioDynamics share count unchanged in Q3 2018.
  • AngioDynamics made up 0.01% of Thompson Davis & Co's portfolio in Q3 2018, its #560 holding.
  • Thompson Davis & Co first reported a position in AngioDynamics in Q4 2013 and has held it in 4 quarters since.
  • Thompson Davis & Co's AngioDynamics position peaked at $9K in Q4 2013.
  • 177 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.